{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T08:29:58Z","timestamp":1782203398061,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1757-2215-7-70","type":"journal-article","created":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T01:04:03Z","timestamp":1403744643000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids"],"prefix":"10.1186","volume":"7","author":[{"given":"Mark","family":"Desjardins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal","family":"Gurler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goda G","family":"Muralidhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle D","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna E","family":"Burdette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria V","family":"Barbolina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,26]]},"reference":[{"key":"279_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA Cancer J Clin 2013, 63: 11\u201330.","journal-title":"CA Cancer J Clin"},{"key":"279_CR2","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMra041842","volume":"351","author":"SA Cannistra","year":"2004","unstructured":"Cannistra SA: Cancer of the ovary. N Engl J Med 2004, 351: 2519\u20132529.","journal-title":"N Engl J Med"},{"key":"279_CR3","first-page":"609","volume":"80","author":"MA Roett","year":"2009","unstructured":"Roett MA, Evans P: Ovarian cancer: an overview. Am Fam Physician 2009, 80: 609\u2013616.","journal-title":"Am Fam Physician"},{"key":"279_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ygyno.2003.12.034","volume":"93","author":"KM Burleson","year":"2004","unstructured":"Burleson KM, Casey RC, Skubitz KM, Pambuccian SE, Oegema TR Jr, Skubitz AP: Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers. Gynecologic Oncology 2004, 93: 170\u2013181.","journal-title":"Gynecologic Oncology"},{"key":"279_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1023\/A:1026519016213","volume":"18","author":"RC Casey","year":"2000","unstructured":"Casey RC, Skubitz AP: CD44 and beta1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins. Clinical & Experimental Metastasis 2000, 18: 67\u201375.","journal-title":"Clinical & Experimental Metastasis"},{"key":"279_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1158\/2159-8274.CD-11-0010","volume":"1","author":"MP Iwanicki","year":"2011","unstructured":"Iwanicki MP, Davidowitz RA, Ng MR, Besser A, Muranen T, Merritt M, Danuser G, Ince TA, Brugge JS: Ovarian cancer spheroids use myosin-generated force to clear the mesothelium. Cancer Discov 2011, 1: 144\u2013157.","journal-title":"Cancer Discov"},{"key":"279_CR7","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0002-9440(10)65406-5","volume":"154","author":"K Lessan","year":"1999","unstructured":"Lessan K, Aguiar DJ, Oegema T, Siebenson L, Skubitz AP: CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. American Journal of Pathology 1999, 154: 1525\u20131537.","journal-title":"American Journal of Pathology"},{"key":"279_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10585-010-9317-0","volume":"27","author":"SM Khan","year":"2010","unstructured":"Khan SM, Funk HM, Thiolloy S, Lotan TL, Hickson J, Prins GS, Drew AF, Rinker-Schaeffer CW: In vitro metastatic colonization of human ovarian cancer cells to the omentum. Clin Exp Metastasis 2010, 27: 185\u2013196.","journal-title":"Clin Exp Metastasis"},{"key":"279_CR9","first-page":"3830","volume":"53","author":"SA Cannistra","year":"1993","unstructured":"Cannistra SA, Kansas GS, Niloff J, DeFranzo B, Kim Y, Ottensmeier C: Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res 1993, 53: 3830\u20133838.","journal-title":"Cancer Res"},{"key":"279_CR10","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1158\/0008-5472.CAN-05-1818","volume":"66","author":"MJ Arlt","year":"2006","unstructured":"Arlt MJ, Novak-Hofer I, Gast D, Gschwend V, Moldenhauer G, Grunberg J, Honer M, Schubiger PA, Altevogt P, Kruger A: Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Cancer Res 2006, 66: 936\u2013943.","journal-title":"Cancer Res"},{"key":"279_CR11","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1158\/0008-5472.CAN-07-5167","volume":"68","author":"K Sawada","year":"2008","unstructured":"Sawada K, Mitra AK, Radjabi AR, Bhaskar V, Kistner EO, Tretiakova M, Jagadeeswaran S, Montag A, Becker A, Kenny HA, Peter ME, Ramakrishnan V, Yamada SD, Lengyel E: Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target. Cancer Res 2008, 68: 2329\u20132339.","journal-title":"Cancer Res"},{"key":"279_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.canlet.2006.03.029","volume":"247","author":"N Scholler","year":"2007","unstructured":"Scholler N, Garvik B, Hayden-Ledbetter M, Kline T, Urban N: Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery. Cancer Lett 2007, 247: 130\u2013136.","journal-title":"Cancer Lett"},{"key":"279_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1006\/gyno.1999.5388","volume":"73","author":"T Strobel","year":"1999","unstructured":"Strobel T, Cannistra SA: Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Gynecol Oncol 1999, 73: 362\u2013367.","journal-title":"Gynecol Oncol"},{"key":"279_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1158\/1541-7786.MCR-11-0256","volume":"10","author":"M Kim","year":"2012","unstructured":"Kim M, Rooper L, Xie J, Kajdacsy-Balla AA, Barbolina MV: Fractalkine receptor CX(3)CR1 is expressed in epithelial ovarian carcinoma cells and required for motility and adhesion to peritoneal mesothelial cells. Mol Cancer Res 2012, 10: 11\u201324.","journal-title":"Mol Cancer Res"},{"key":"279_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10585-010-9363-7","volume":"28","author":"MP Ween","year":"2011","unstructured":"Ween MP, Hummitzsch K, Rodgers RJ, Oehler MK, Ricciardelli C: Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides. Clin Exp Metastasis 2011, 28: 113\u2013125.","journal-title":"Clin Exp Metastasis"},{"key":"279_CR16","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1172\/JCI33775","volume":"118","author":"HA Kenny","year":"2008","unstructured":"Kenny HA, Kaur S, Coussens LM, Lengyel E: The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest 2008, 118: 1367\u20131379.","journal-title":"J Clin Invest"},{"key":"279_CR17","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/(SICI)1097-0215(19970904)72:5<851::AID-IJC23>3.0.CO;2-A","volume":"72","author":"IV Filippovich","year":"1997","unstructured":"Filippovich IV, Sorokina NI, Robillard N, Chatal JF: Radiation-induced apoptosis in human ovarian carcinoma cells growing as a monolayer and as multicell spheroids. International Journal of Cancer 1997, 72: 851\u2013859.","journal-title":"International Journal of Cancer"},{"key":"279_CR18","first-page":"515","volume":"14","author":"S Makhija","year":"1999","unstructured":"Makhija S, Taylor DD, Gibb RK, Gercel-Taylor C: Taxol-induced bcl-2 phosphorylation in ovarian cancer cell monolayer and spheroids. International Journal of Oncology 1999, 14: 515\u2013521.","journal-title":"International Journal of Oncology"},{"key":"279_CR19","first-page":"87","volume":"11","author":"RM Sutherland","year":"1976","unstructured":"Sutherland RM, Durand RE: Radiation response of multicell spheroids\u2013an in vitro tumour model. Curr Top Radiat Res Q 1976, 11: 87\u2013139.","journal-title":"Curr Top Radiat Res Q"},{"key":"279_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0955-0674(02)00375-7","volume":"14","author":"TN Wight","year":"2002","unstructured":"Wight TN: Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 2002, 14: 617\u2013623.","journal-title":"Curr Opin Cell Biol"},{"key":"279_CR21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/sj.cr.7290318","volume":"15","author":"YJ Wu","year":"2005","unstructured":"Wu YJ, La Pierre DP, Wu J, Yee AJ, Yang BB: The interaction of versican with its binding partners. Cell Res 2005, 15: 483\u2013494.","journal-title":"Cell Res"},{"key":"279_CR22","doi-asserted-by":"publisher","first-page":"12294","DOI":"10.1074\/jbc.M110748200","volume":"277","author":"Y Wu","year":"2002","unstructured":"Wu Y, Chen L, Zheng PS, Yang BB: beta 1-Integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M\/versican. J Biol Chem 2002, 277: 12294\u201312301.","journal-title":"J Biol Chem"},{"key":"279_CR23","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1242\/jcs.01516","volume":"117","author":"PS Zheng","year":"2004","unstructured":"Zheng PS, Vais D, Lapierre D, Liang YY, Lee V, Yang BL, Yang BB: PG-M\/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation. J Cell Sci 2004, 117: 5887\u20135895.","journal-title":"J Cell Sci"},{"key":"279_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/jcp.10043","volume":"190","author":"JM Lemire","year":"2002","unstructured":"Lemire JM, Merrilees MJ, Braun KR, Wight TN: Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro. J Cell Physiol 2002, 190: 38\u201345.","journal-title":"J Cell Physiol"},{"key":"279_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1006\/dbio.1998.9001","volume":"202","author":"CH Mjaatvedt","year":"1998","unstructured":"Mjaatvedt CH, Yamamura H, Capehart AA, Turner D, Markwald RR: The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev Biol 1998, 202: 56\u201366.","journal-title":"Dev Biol"},{"key":"279_CR26","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1091\/mbc.E04-04-0295","volume":"16","author":"W Sheng","year":"2005","unstructured":"Sheng W, Wang G, Wang Y, Liang J, Wen J, Zheng PS, Wu Y, Lee V, Slingerland J, Dumont D, Yang BB: The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. Mol Biol Cell 2005, 16: 1330\u20131340.","journal-title":"Mol Biol Cell"},{"key":"279_CR27","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1091\/mbc.E05-10-0951","volume":"17","author":"W Sheng","year":"2006","unstructured":"Sheng W, Wang G, La Pierre DP, Wen J, Deng Z, Wong CK, Lee DY, Yang BB: Versican mediates mesenchymal-epithelial transition. Mol Biol Cell 2006, 17: 2009\u20132020.","journal-title":"Mol Biol Cell"},{"key":"279_CR28","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/j.1460-2075.1989.tb08447.x","volume":"8","author":"DR Zimmermann","year":"1989","unstructured":"Zimmermann DR, Ruoslahti E: Multiple domains of the large fibroblast proteoglycan, versican. Embo J 1989, 8: 2975\u20132981.","journal-title":"Embo J"},{"key":"279_CR29","doi-asserted-by":"publisher","first-page":"13019","DOI":"10.1074\/jbc.M411766200","volume":"280","author":"M Rahmani","year":"2005","unstructured":"Rahmani M, Read JT, Carthy JM, McDonald PC, Wong BW, Esfandiarei M, Si X, Luo Z, Luo H, Rennie PS, McManus BM: Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells. J Biol Chem 2005, 280: 13019\u201313028.","journal-title":"J Biol Chem"},{"key":"279_CR30","doi-asserted-by":"publisher","first-page":"12306","DOI":"10.1074\/jbc.M807108200","volume":"284","author":"C Domenzain-Reyna","year":"2009","unstructured":"Domenzain-Reyna C, Hernandez D, Miquel-Serra L, Docampo MJ, Badenas C, Fabra A, Bassols A: Structure and regulation of the versican promoter: the versican promoter is regulated by AP-1 and TCF transcription factors in invasive human melanoma cells. J Biol Chem 2009, 284: 12306\u201312317.","journal-title":"J Biol Chem"},{"key":"279_CR31","doi-asserted-by":"publisher","first-page":"31954","DOI":"10.1074\/jbc.M702099200","volume":"282","author":"JT Read","year":"2007","unstructured":"Read JT, Rahmani M, Boroomand S, Allahverdian S, McManus BM, Rennie PS: Androgen receptor regulation of the versican gene through an androgen response element in the proximal promoter. J Biol Chem 2007, 282: 31954\u201331963.","journal-title":"J Biol Chem"},{"key":"279_CR32","doi-asserted-by":"publisher","first-page":"23241","DOI":"10.1074\/jbc.M109.084673","volume":"285","author":"X Wang","year":"2010","unstructured":"Wang X, Hu G, Zhou J: Repression of versican expression by microRNA-143. J Biol Chem 2010, 285: 23241\u201323250.","journal-title":"J Biol Chem"},{"key":"279_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1139\/y05-154","volume":"84","author":"M Rahmani","year":"2006","unstructured":"Rahmani M, Wong BW, Ang L, Cheung CC, Carthy JM, Walinski H, McManus BM: Versican: signaling to transcriptional control pathways. Can J Physiol Pharmacol 2006, 84: 77\u201392.","journal-title":"Can J Physiol Pharmacol"},{"key":"279_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ijc.11423","volume":"107","author":"K Voutilainen","year":"2003","unstructured":"Voutilainen K, Anttila M, Sillanpaa S, Tammi R, Tammi M, Saarikoski S, Kosma VM: Versican in epithelial ovarian cancer: relation to hyaluronan, clinicopathologic factors and prognosis. Int J Cancer 2003, 107: 359\u2013364.","journal-title":"Int J Cancer"},{"key":"279_CR35","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ygyno.2010.05.029","volume":"119","author":"S Ghosh","year":"2010","unstructured":"Ghosh S, Albitar L, LeBaron R, Welch WR, Samimi G, Birrer MJ, Berkowitz RS, Mok SC: Up-regulation of stromal versican expression in advanced stage serous ovarian cancer. Gynecol Oncol 2010, 119: 114\u2013120.","journal-title":"Gynecol Oncol"},{"key":"279_CR36","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3390\/ijms12021009","volume":"12","author":"MP Ween","year":"2011","unstructured":"Ween MP, Oehler MK, Ricciardelli C: Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis. Int J Mol Sci 2011, 12: 1009\u20131029.","journal-title":"Int J Mol Sci"},{"key":"279_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20110112","volume":"437","author":"MV Barbolina","year":"2011","unstructured":"Barbolina MV, Burkhalter RJ, Stack MS: Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment. Biochem J 2011, 437: 1\u201312.","journal-title":"Biochem J"},{"key":"279_CR38","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/modpathol.2010.154","volume":"23","author":"A Gorter","year":"2010","unstructured":"Gorter A, Zijlmans HJ, van Gent H, Trimbos JB, Fleuren GJ, Jordanova ES: Versican expression is associated with tumor-infiltrating CD8-positive T cells and infiltration depth in cervical cancer. Mod Pathol 2010, 23: 1605\u20131615.","journal-title":"Mod Pathol"},{"key":"279_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s10585-004-5768-5","volume":"21","author":"KM Burleson","year":"2004","unstructured":"Burleson KM, Hansen LK, Skubitz AP: Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers. Clinical & Experimental Metastasis 2004, 21: 685\u2013697.","journal-title":"Clinical & Experimental Metastasis"},{"key":"279_CR40","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/labinvest.2008.25","volume":"88","author":"M Barbolina","year":"2008","unstructured":"Barbolina M, Adley BP, Kelly DL, Fought AJ, Scholtens DM, Shea LD, Stack MS: Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma. Lab Invest. 2008, 88: 602\u2013614.","journal-title":"Lab Invest"},{"key":"279_CR41","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1074\/jbc.M608428200","volume":"282","author":"MV Barbolina","year":"2007","unstructured":"Barbolina MV, Adley BP, Ariztia EV, Liu Y, Stack MS: Microenvironmental Regulation of Membrane Type 1 Matrix Metalloproteinase Activity in Ovarian Carcinoma Cells via Collagen-induced EGR1 Expression. J Biol Chem 2007, 282: 4924\u20134931.","journal-title":"J Biol Chem"},{"key":"279_CR42","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/cncr.23341","volume":"112","author":"MV Barbolina","year":"2008","unstructured":"Barbolina MV, Adley BP, Shea LD, Stack MS: Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion. Cancer 2008, 112: 1632\u20131641.","journal-title":"Cancer"},{"key":"279_CR43","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1158\/1541-7786.MCR-12-0361","volume":"10","author":"M Kim","year":"2012","unstructured":"Kim M, Rooper L, Xie J, Rayahin J, Burdette JE, Kajdacsy-Balla A, Barbolina MV: The Lymphotactin Receptor Is Expressed in Epithelial Ovarian Carcinoma and Contributes to Cell Migration and Proliferation. Mol Cancer Res 2012, 10: 1419.","journal-title":"Mol Cancer Res"},{"key":"279_CR44","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/ncomms3126","volume":"4","author":"S Domcke","year":"2013","unstructured":"Domcke S, Sinha R, Levine DA, Sander C, Schultz N: Evaluating cell lines as tumour models by comparison of genomic profiles. Nat Commun 2013, 4: 2126.","journal-title":"Nat Commun"},{"key":"279_CR45","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N: The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov 2012, 2: 401\u2013404.","journal-title":"Cancer Discov"},{"key":"279_CR46","first-page":"269","volume":"27","author":"D Hernandez","year":"2011","unstructured":"Hernandez D, Miquel-Serra L, Docampo MJ, Marco-Ramell A, Bassols A: Role of versican V0\/V1 and CD44 in the regulation of human melanoma cell behavior. Int J Mol Med 2011, 27: 269\u2013275.","journal-title":"Int J Mol Med"},{"key":"279_CR47","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1002\/ijc.24188","volume":"124","author":"KL Sodek","year":"2009","unstructured":"Sodek KL, Ringuette MJ, Brown TJ: Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype. Int J Cancer 2009, 124: 2060\u20132070.","journal-title":"Int J Cancer"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1757-2215-7-70.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:32:47Z","timestamp":1630557167000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/1757-2215-7-70"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,26]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["279"],"URL":"https:\/\/doi.org\/10.1186\/1757-2215-7-70","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,26]]},"assertion":[{"value":"20 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"70"}}